{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:27:13Z","timestamp":1775784433687,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.humpath.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T15:06:49Z","timestamp":1413299209000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas"],"prefix":"10.1016","volume":"46","author":[{"given":"Anja C.","family":"Roden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhee S.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis L.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Cassivi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda I.","family":"Garces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randolph S.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2014.10.001_bb0005","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2009.11.057","article-title":"Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma","volume":"89","author":"Hosaka","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2014.10.001_bb0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ijc.10255","article-title":"Histologic classification of thymic epithelial tumors: comparison of established classification schemes","volume":"98","author":"Rieker","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2014.10.001_bb0015","series-title":"Tumours of the lung, pleura, thymus and heart","first-page":"146","article-title":"Tumours of the thymus","author":"Mueller-Hermelink","year":"2004"},{"key":"10.1016\/j.humpath.2014.10.001_bb0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.lungcan.2012.11.015","article-title":"Reproducibility of the WHO classification of thymomas: practical implications","volume":"79","author":"Zucali","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.humpath.2014.10.001_bb0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2559.2008.03088.x","article-title":"Interobserver variation in the classification of thymic tumours\u2014a multicentre study using the WHO classification system","volume":"53","author":"Verghese","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.10.001_bb0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.5858\/arpa.2013-0028-OA","article-title":"Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopy","volume":"138","author":"Wang","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2014.10.001_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11748-012-0187-z","article-title":"Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians","volume":"61","author":"Sakakura","year":"2013","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.humpath.2014.10.001_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcp\/109.6.722","article-title":"CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms","volume":"109","author":"Kornstein","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0045","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/PAS.0b013e31802b4917","article-title":"Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms","volume":"31","author":"Nonaka","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/modpathol.2009.105","article-title":"Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms","volume":"22","author":"Kojika","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2014.10.001_bb0060","first-page":"131","article-title":"The biology of cell death in tumours","volume":"5","author":"Wyllie","year":"1985","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2014.10.001_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/106689690401200412","article-title":"KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors","volume":"12","author":"Comin","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0070","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1010-7940(01)00776-X","article-title":"The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters","volume":"20","author":"Salakou","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.humpath.2014.10.001_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","article-title":"Expression of apoptosis-related markers and HER-2\/neu in thymic epithelial tumours","volume":"43","author":"Pan","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.10.001_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1699-0463.1998.tb01370.x","article-title":"Expression of bcl-2 in fetal thymus, thymomas and thymic carcinomas. Association with p53 expression and review of the literature","volume":"106","author":"Engel","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2014.10.001_bb0085","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/01.MP.0000038463.67854.84","article-title":"Proliferative activity and apoptosis in thymic epithelial neoplasms","volume":"15","author":"Hiroshima","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2005.05.009","article-title":"World Health Organization histologic classification: an independent prognostic factor in resected thymomas","volume":"50","author":"Rena","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.humpath.2014.10.001_bb0095","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2014.10.001_bb0100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1378\/chest.127.3.755","article-title":"Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review","volume":"127","author":"Kim","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2014.10.001_bb0105","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s12032-011-0101-z","article-title":"Association of clinical and pathological variables with survival in thymoma","volume":"29","author":"Aydiner","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2014.10.001_bb0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","article-title":"Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms","volume":"111","author":"Suster","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0120","series-title":"R: a language and environment for statistical computing","author":"Team RDC","year":"2011"},{"key":"10.1016\/j.humpath.2014.10.001_bb0125","series-title":"Technical Report Series No. 61","article-title":"An Introduction to Recursive PArtitioning using the RPART Routines","author":"Atkinson","year":"1997"},{"key":"10.1016\/j.humpath.2014.10.001_bb0130","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cncr.23492","article-title":"Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma","volume":"112","author":"Marchevsky","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.10.001_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network","volume":"2","author":"Klapper","year":"2009","journal-title":"J Hematop"},{"key":"10.1016\/j.humpath.2014.10.001_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jclinpath-2011-200532","article-title":"Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa","volume":"65","author":"Gunia","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.10.001_bb0145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-013-1408-2","article-title":"Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids","volume":"462","author":"Warth","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2014.10.001_bb0155","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.athoracsur.2005.11.067","article-title":"Clinical value of the WHO classification system of thymoma","volume":"81","author":"Detterbeck","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2014.10.001_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2559.1998.00504.x","article-title":"Ki67 labelling index correlates with stage and histology but not significantly with prognosis in thymoma","volume":"33","author":"Pan","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.10.001_bb0170","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2014.10.001_bb0175","first-page":"3714","article-title":"Paradoxical inhibition of solid tumor cell growth by bcl2","volume":"54","author":"Pietenpol","year":"1994","journal-title":"Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714004079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714004079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T18:09:30Z","timestamp":1572631770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817714004079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0046817714004079"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2014.10.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}